Wednesday, 30 January 2013

Belarus Pharmaceuticals and Healthcare Market Report Q1 2013

Business Monitor International Market Research Reports
Market Reports Online XML Feed
Belarus Pharmaceuticals and Healthcare Report Q1 2013
Jan 30th 2013, 00:00

BMI View: We remain largely pessimistic about Belarus?s pharmaceutical market development, at leastin the short term. The government remains committed to boosting domestic pharmaceutical output overthe coming years, with authorities in manufacturing joint venture (JV) discussions with a number ofcountries. However, the devalued ruble, high inflation and weak household consumption will continue toconstrain both the volume and value of medicines consumed in Belarus. We also note increased politicaland economic risks, as the country aligns itself away from the European Union.Headline Expenditure Projections:?? Pharmaceuticals: BYR3,598bn in 2011 (US$692mn) to BYR5,6...

Delicious Digg Evernote Facebook Google Bookmarks Google Plus LinkedIn StumbleUpon Tumblr Twitter
You are receiving this email because you subscribed to this feed at

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment